A novel
proteolytic enzyme with fibrinolytic activity,
FSP3, was purified from the recently isolated Streptomyces sp. P3, which is a novel bacterial strain isolated from soil.
FSP3 was purified to electrophoretic homogeneity by
ammonium sulfate precipitation,
anion exchange, and gel filtration.
FSP3 is considered to be a single
peptide chain with a molecular mass of 44 kDa. The maximum activity of the
enzyme was observed at 50°C and pH 6.5, and the
enzyme was stable between pH 6 and 8 and below 40°C. In a
fibrin plate assay,
FSP3 showed more potent fibrinolytic activity than
urokinase, which is a clinical
thrombolytic agent acting as a
plasminogen activitor. The activity was strongly inhibited by the
serine protease inhibitor PMSF, indicating that it is a
serine protease. Additionally,
metal ions showed different effects on the activity. It was significantly suppressed by Mg(2+) and Ca(2+) and completely inhibited by Cu(2+), but slightly enhanced by Fe(2+). According to LC-MS/MS results, its partial amino acid sequences are significantly dissimilar from those of previously reported fibrinolytic
enzymes. The sequence of
a DNA fragment encoding
FSP3 contained an open reading frame of 1287 base pairs encoding 428
amino acids.
FSP3 is a bifunctional
enzyme in nature. It hydrolyzes the
fibrin directly and activates
plasminogen, which may reduce the occurrence of side effects. These results suggest that
FSP3 is a novel
serine protease with potential applications in
thrombolytic therapy.